Navigation Links
Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Date:12/10/2010

needs. Amgen is studying denosumab in numerous tumor types across the spectrum of cancer-related bone diseases. Over 11,000 patients have been enrolled in the denosumab oncology clinical trials. In addition to this newly approved indication, XGEVA is also being investigated for its potential to delay bone metastases in prostate and breast cancer.

About AmgenAmgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com/.

Forward-Looking Statements This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Amgen to Present at Deutsche Banks 2010 BioFEST
2. Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
3. Amgen Foundation and Ashokas Changemakers Announce Finalists in Patients
4. Choices
5. Empowerment Competition
6. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
7. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
8. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
9. Amgen Announces Webcast of 2010 Third Quarter Financial Results
10. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
11. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Faruqi & Faruqi, LLP, a leading ... fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the ... ) The investigation focuses on ... securities laws by issuing materially false and/or misleading ... for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the investigation ...
(Date:5/17/2013)... May 17, 2013  Sorrento Therapeutics, Inc. (OTCBB: ... Advanced Technology Small Business Technology Transfer Research (STTR) ... and Infectious Diseases (NIAID), a division of the ... of novel human antibody therapeutics to combat ... Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... 8-well strip holder and 130um sorting chip.  Sony will also ... on its new SH800 Cell Sorter, the EC800 flow cytometer, ... tutorials at CYTO 2013, which will be held at the ... San Diego, California , from May 20 - ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
(Date:5/18/2013)... Gordon HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... sometimes binge drink, but new research shows that college women ... a weekly basis than are college men. Much ... that,s considered safe on a weekly basis is much lower ... women versus 14 for men. But, there,s good reason for ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss products ... result of stress, nutrient deficiency or wearing a favorite ... men suffer from male patterned baldness. , ... transplant surgery, but additionally carries a hair care product ... Professional Strength. Their product line is a five-step treatment ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic ... Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global ... and studies the major market drivers, restraints, and opportunities ... World. , Browse , 147 ... , 318 pagesand in-depth TOC of ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... May 26, 2011Folic acid supplements given to pregnant and ... their offspring by 64 per cent, a new study ... Kim, a gastroenterologist at St. Michael,s Hospital, adds to ... supplementation during pregnancy and lactation can increase or decrease ...
... HealthDay Reporter , THURSDAY, May 26 (HealthDay ... of babes, but their minds are able to form ... new study suggests. Joined by colleagues across the ... has developed a computational model of preverbal infants, "pure ...
... , THURSDAY, May 26 (HealthDay News) -- Caffeine, a ... nausea, anxiety and depression. Now, new research reveals that caffeine ... pregnant. By analyzing fallopian tubes in mice, researchers found ... from the ovaries through the fallopian tubes and into the ...
... is available in French and Spanish . ... that music therapy combined with other relax techniques based on ... sleep among patients suffering from fibromyalgia. Thus, this therapy enhances ... has shown that these two techniques enhance the well-being and ...
... danger to human populations. Indeed, exposure to nuclear radiation leads ... according to a new study by Hagen Scherb and Kristina ... radiation from atomic bomb testing before the Partial Test Ban ... nuclear facilities, has had a long-term negative effect on the ...
... recently approved by the Food & Drug Administration for the treatment ... of time. A new study shows abiraterone acetate extends the ... by about four months. The study in the May 26, 2011 ... co-authored by Thomas W. Flaig, MD, medical oncologist at the University ...
Cached Medicine News:Health News:Folic acid given to mother rats protects offspring from colon cancer 2Health News:Babies May Perform 'Pure Reasoning,' Study Suggests 2Health News: Caffeine May Interfere With Fertility in Women 2Health News:Music therapy relieves fibromyalgia symptoms and improves patients' quality of life 2Health News:Nuclear radiation affects baby gender 2Health News:New drug treatment extends lives of men with prostate cancer 2
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
Inquire...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: